STRATEGY-NNRTI is a 96 week , international , multicentre , randomised , open-label , phase 3b , non-inferiority trial enrolling adults ( 18 years ) with HIV-1 and plasma HIV RNA viral load below 50 copies per mL for at least 6 months on an NNRTI plus emtricitabine and tenofovir regimen .